Mimerse

Our target outcomes:

As our solution is automated, it will be an important factor of solving the inherent scalability problem with psychological treatments today - i.e. the Mental Health Treatment Gap.

Before mainstream adoption of VR, a large userbase will be clinicians offering our treatments to their patients and clients. 

After mainstream adoption of VR people will download Mimerse as an app, same place as where they get other VR content, and upon opening the application users will select from one or several things/symptoms they want to work on.

How we will measure our progress:

• Outcome: Clinical trial results
  Measurement Plan: Published papers
• Outcome: 100.000 downloads of first demo
  Measurement Plan: Track downloads in the app store
• Outcome: B2B revenue
  Measurement Plan: Financial model

The populations we will benefit initially:

• Adult
• High-income economies
• Upper middle income economies (between $3976 and $12275 GNI)
• Non-binary
• Urban

The regions we will benefit initially:

• Europe and Central Asia
• US and Canada

The technologies we employ:

• Consumer-facing software (mobile applications, cloud services)
• Digital systems (machine learning, control systems, big data)
• Something so new it doesn’t have a name

Why our solution is unique:

We are committed and focused on self administered, evidence-based direct to consumer VR treatments. We are unique in that we have the worlds first randomized controlled trial of such an application. Going forward we will be unique by not have different apps but collecting all treatments in one platform, one app.

We have unique clinical partnerships with Sweden's largest hospitals, best universities and specialist clinics as well as collaborations hardware manufacturers.

We will stand out in that we have design and production standards on par with modern games.

Why our solution is human-centered:

Development of our treatments involve the relevant patient groups and mental health professionals from day one. First we test with prototypes to measure reactions and feedback and to generate ideas and insights of how they themselves would like to use the technology. Then we use a larger sample of the same patient group for the clinical trials and end up with a product that is used directly at ease and benefit from that group of individuals. 

Scientifically evaluating what effect our technology has on the user is a core value for us at Mimerse.

How people will access our solution:

Mimerse will be deployed as a download in VR-app stores and mediated through companies like Facebook, Google and Samsung.

As time progresses and VR penetration deepens, adoption is likely to follow that of the smartphone in terms of demographics.

Until VR/AR is commonplace people will be able to access our solutions through clinicians and other stakeholders in mental health who supply the VR headset to the user.

Technology-Readiness Level:

http://www.mimerse.com

https://www.oculus.com/experiences/gear-vr/1046954465328733/

Our organization:

How we will sustain our team financially:

Venture capital, soft funding and income from app sales and publishing deals.

The factors limiting our success:

- Lack of funding

- Small (but rapidly growing) VR userbase

- Clinical data publication time lag

How long we have been working on our solution:

How long it will take to develop a pilot:

How long it will take to scale beyond our pilot:

Our expected annual budget:

$800000

How much of our budget we've secured to date:

$50000

http://www.allabolag.se/5569802662/mimerse-ab

https://www.youtube.com/watch?v=iNk80PUSsDI&list=PLClMJkJnjHH9ZLCzZCJiMmSvGIFHksHCp&index=1:cc=on

Our promotional materials:

https://www.youtube.com/playlist?list=PLuwuLksA9Vj_OArdbSrTFykKuijtaF522

https://www.ncbi.nlm.nih.gov/pubmed/28270059

We're looking for partners in these fields:

• Behavioral / Mental Health
• General Wellness
• Digital Health

Why we're applying to Solve:

Network

Clinical collaborators

Commercial collaborators

Stamp of approval

Our current partners:

Samsung

Cerner

Karolinska Institutet

Stockholm University

Sahlgrenska University Hospital

Stockholm South General Hospital

Apotek Hjärtat (Swedish chain of pharmacies)

Stockholm center for eating disorders (SCÄ)